Manulife (Manufacturers Life Insurance)’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.76M | Buy |
208,010
+54,858
| +36% | +$1.78M | 0.01% | 1026 |
|
|
2025
Q1 | $5.78M | Sell |
153,152
-5,376
| -3% | -$203K | 0.01% | 1109 |
|
|
2024
Q4 | $13M | Buy |
158,528
+1,504
| +1% | +$123K | 0.01% | 761 |
|
|
2024
Q3 | $17.9M | Buy |
157,024
+25,275
| +19% | +$2.89M | 0.02% | 665 |
|
|
2024
Q2 | $9.95M | Buy |
131,749
+12,667
| +11% | +$956K | 0.01% | 843 |
|
|
2024
Q1 | $8.13M | Buy |
119,082
+14,009
| +13% | +$957K | 0.01% | 957 |
|
|
2023
Q4 | $6.6M | Buy |
105,073
+12,249
| +13% | +$769K | ﹤0.01% | 1041 |
|
|
2023
Q3 | $4.73M | Buy |
92,824
+11,135
| +14% | +$568K | ﹤0.01% | 1139 |
|
|
2023
Q2 | $4.08M | Buy |
81,689
+52,729
| +182% | +$2.63M | ﹤0.01% | 1185 |
|
|
2023
Q1 | $1.09M | Buy |
28,960
+463
| +2% | +$17.4K | ﹤0.01% | 1596 |
|
|
2022
Q4 | $1.37M | Buy |
28,497
+7,754
| +37% | +$372K | ﹤0.01% | 1490 |
|
|
2022
Q3 | $498K | Sell |
20,743
-13
| -0.1% | -$312 | ﹤0.01% | 1975 |
|
|
2022
Q2 | $452K | Buy |
20,756
+3,247
| +19% | +$70.7K | ﹤0.01% | 2118 |
|
|
2022
Q1 | $423K | Sell |
17,509
-3,971
| -18% | -$95.9K | ﹤0.01% | 2296 |
|
|
2021
Q4 | $511 | Buy |
21,480
+101
| +0.5% | +$2 | ﹤0.01% | 2241 |
|
|
2021
Q3 | $542K | Sell |
21,379
-1,509
| -7% | -$38.3K | ﹤0.01% | 2230 |
|
|
2021
Q2 | $515K | Buy |
22,888
+6,249
| +38% | +$141K | ﹤0.01% | 2405 |
|
|
2021
Q1 | $329K | Buy |
16,639
+5,379
| +48% | +$106K | ﹤0.01% | 2555 |
|
|
2020
Q4 | $299K | Buy |
11,260
+1,297
| +13% | +$34.4K | ﹤0.01% | 2520 |
|
|
2020
Q3 | $492K | Buy |
+9,963
| New | +$492K | ﹤0.01% | 2010 |
|